Matt Abernethy serves as Executive at NEUROCRINE BIOSCIENCES INC, where they oversee executive responsibilities. Since joining the company, Matt Abernethy has executed 38 insider transactions totaling $14.4M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 31, 2026 involved exercising options for 2,437 shares valued at $0.
Matt Abernethy currently holds 37,097 shares of NEUROCRINE BIOSCIENCES INC (NBIX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Matt Abernethy has been a net seller of NBIX stock. They have purchased $0 and sold $14.4M worth of shares.
Matt Abernethy's most recent insider trade was on Jan 31, 2026, when they sold 2,437 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $136.06 |
| Discretionary |
| Jan 31, 2026 | NBIX | $0 | Option Exercise | 2,437 | $N/A | Discretionary |
| Aug 13, 2024 | NBIX | $2.1M | Sale | 14,100 | $150.38 | Planned |
| Aug 13, 2024 | NBIX | $1.0M | Option Exercise | 14,100 | $73.60 | Planned |
| Jul 16, 2024 | NBIX | $66.2K | Option Exercise | 900 | $73.60 | Planned |
| Jul 16, 2024 | NBIX | $135.0K | Sale | 900 | $150.04 | Planned |
| May 15, 2024 | NBIX | $1.1M | Option Exercise | 15,000 | $73.60 | Planned |
| May 15, 2024 | NBIX | $2.1M | Sale | 15,000 | $140.24 | Planned |
| May 14, 2024 | NBIX | $1.1M | Option Exercise | 15,000 | $73.60 | Planned |
| May 14, 2024 | NBIX | $2.0M | Sale | 15,000 | $135.66 | Planned |
| Feb 13, 2024 | NBIX | $179.6K | Sale | 1,352 | $132.85 | Planned |
| Feb 8, 2024 | NBIX | $131.5K | Sale | 980 | $134.21 | Planned |
| Feb 6, 2024 | NBIX | $182.0K | Sale | 1,280 | $142.19 | Planned |
| Jan 31, 2024 | NBIX | $180.5K | Sale | 1,283 | $140.72 | Planned |
| Aug 21, 2023 | NBIX | $229.0K | Sale | 2,132 | $107.39 | Planned |
| Feb 8, 2023 | NBIX | $102.1K | Sale | 980 | $104.19 | Discretionary |
| Feb 7, 2023 | NBIX | $1.3M | Sale | 12,807 | $102.42 | Discretionary |
| Feb 7, 2023 | NBIX | $1.2M | Sale | 11,491 | $102.40 | Discretionary |
| Feb 7, 2023 | NBIX | $207.7K | Sale | 2,030 | $102.33 | Discretionary |
| Feb 6, 2023 | NBIX | $135.3K | Sale | 1,280 | $105.67 | Discretionary |
| Jan 31, 2023 | NBIX | $141.1K | Sale | 1,283 | $109.98 | Discretionary |
| Feb 8, 2022 | NBIX | $78.1K | Sale | 980 | $79.65 | Discretionary |
| Feb 7, 2022 | NBIX | $103.4K | Sale | 1,280 | $80.78 | Discretionary |
| Feb 7, 2022 | NBIX | $164.0K | Sale | 2,030 | $80.80 | Discretionary |
| Dec 1, 2021 | NBIX | $135.9K | Sale | 1,645 | $82.59 | Discretionary |
| Feb 8, 2021 | NBIX | $102.8K | Sale | 880 | $116.85 | Discretionary |
| Feb 8, 2021 | NBIX | $237.1K | Sale | 2,030 | $116.81 | Discretionary |
| Dec 1, 2020 | NBIX | $155.7K | Sale | 1,645 | $94.66 | Discretionary |
| Nov 12, 2020 | NBIX | $204.8K | Sale | 2,257 | $90.74 | Discretionary |